Deliver An Omnichannel Experience With Medical Affairs Global Content Strategies

Reach your audience faster in a conceptually equivalent, culturally appropriate and compliant way.

Learn more
Healthcare global with hand reaching out to connect

Customer-centric focus to effectively engage and educate key stakeholders, no matter the language

Increasingly specialty medicine requires increasingly specialized education. The methods to deliver digital content are multiplying. The way physicians consume medical content is evolving. All of the above create complexity for medical affairs teams trying to deliver high-quality, engaging content.

With 30+ years of experience, TransPerfect Life Sciences helps MedAffairs teams adapt their communications to effectively reach patients, sponsors, CROs, HCPs, and the general public in compliance with local regulations.

patient engagement in clinical R&D

Evolve Your Medical Affairs Operations From a Regional to a Global Integrated Model

With our expert localization and content adaption service for medical affairs teams, we have helped them see a reduction in content development costs by over 25%.

Why Choose TransPerfect Life Sciences for your Medical Affairs Content Creation and Adaption?

  • >25% Reduction in Content Development Costs
  • Future-Proof Scalability with Technology Driven Workflows and Integrations
  • Flexible and Customizable
  • Fully Integrated Model With Knowledge Management Systems and Processes

Even simple changes to the language of medical affairs content can significantly impact the effectiveness of global messaging.

We make sure your communications relay exactly what you mean, regardless of who you’re speaking to.

News and Press Releases

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations.

The 5-Step AI Readiness Checklist for Medical Device Manufacturers

Only one in four manufacturers using process AI say it's meeting expectations. The gap between those results and the rest comes down to preparation. This checklist is built from patterns shared by manufacturers that are seeing results, along with the gaps most commonly found among those that aren't. ...

The 5-Step AI Readiness Checklist for Medical Device Manufacturers

XTalks | How MI, PV & Regulatory Collaborate on Signals, Labeling, Crisis Response and AI

Medical Information (MI), Pharmacovigilance (PV) and Regulatory Affairs (RA) each play distinct but deeply interconnected roles in ensuring that therapeutics are safe, accurately labeled and compliantly communicated to healthcare professionals and patients. Yet in practice, the ...

C3 Summit 2026 - San Francisco

Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to ...

LifeSci Talks COA Series | Nothing Remains the Same: Why Measures Have to Evolve

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with RJ Wirth, CEO and Consulting Psychometrician at Vector Psychometric Group, to talk about why the measures we rely on are living things rather than fixed artifacts. ...

Regulatory Considerations for Paper COA Translations | What You Need to Know

Collecting data for a global clinical trial on paper COAs or managing a mixed-mode study that combines both paper and electronic formats means satisfying multiple regulatory bodies before a single patient enrolls. None of these entities operate on the same timeline or...

When "How Does the Patient Feel?" Became a Regulatory Question

For decades, clinical trials were built around things you could measure with a machine: tumor shrinkage on a scan, laboratory values, and disease progression. These hard, objective endpoints were the backbone of drug approval. The patient's own account of how they felt,...

XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials

Despite two decades of technological advancement, the debate between paper and electronic clinical outcome assessments (eCOA) remains unresolved. This webinar revisits the assumptions that continue to shape data collection strategies and examines whether current practice reflects ...

Interested in learning how we can help your Medical Affairs content strategies?